Reviva Pharmaceuticals Holdings Stock Price on November 25, 2024
| RVPHW Stock | USD 0.23 0.04 21.05% |
Below is the normalized historical share price chart for Reviva Pharmaceuticals Holdings extending back to October 18, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Reviva Pharmaceuticals stands at 0.23, as last reported on the 28th of November, with the highest price reaching 0.23 and the lowest price hitting 0.23 during the day.
If you're considering investing in Reviva Stock, it is important to understand the factors that can impact its price. Reviva Pharmaceuticals is out of control given 3 months investment horizon. Reviva Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.14, which implies the firm had a 0.14% return per unit of risk over the last 3 months. We have analyze and collected data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 2.81% are justified by taking the suggested risk. Use Reviva Pharmaceuticals Risk Adjusted Performance of 0.1311, coefficient of variation of 630.89, and Semi Deviation of 15.23 to evaluate company specific risk that cannot be diversified away.
At this time, Reviva Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation is likely to climb to about 3.6 M in 2024, whereas Common Stock Total Equity is likely to drop 847.55 in 2024. . At this time, Reviva Pharmaceuticals' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is expected to grow at the current pace this year, whereas Price To Operating Cash Flows Ratio is likely to drop (4.54) in 2024. Reviva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of October 2018 | Beta (0.06) |
Reviva |
Sharpe Ratio = 0.1438
| Best Portfolio | Best Equity | |||
| Good Returns | RVPHW | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 19.56 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.81 actual daily | 56 56% of assets have lower returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average Reviva Pharmaceuticals is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Reviva Pharmaceuticals by adding it to a well-diversified portfolio.
Book Value 0.205 | Shares Float 26.7 M | Market Capitalization 85.8 M | Shares Short Prior Month 2.1 K | Shares Short 14.4 K |
Reviva Pharmaceuticals Main Headline on 25th of November 2024
Discretionary transaction by Patel Purav of tradable shares ... by MacroaxisInsider
Filed transaction by Reviva Pharmaceuticals Holdings Director. Discretionary transaction in accordance with Rule 16b-3
Reviva Pharmaceuticals Valuation on November 25, 2024
It is possible to determine the worth of Reviva Pharmaceuticals on a given historical date. On November 25, 2024 Reviva was worth 0.21 at the beginning of the trading date compared to the closed value of 0.21. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Reviva Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Reviva Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Reviva Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Reviva Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.21 | 0.21 | 0.21 | 0.21 | 101.00 | |
11/25/2024 | 0.21 | 0.22 | 0.21 | 0.21 | 6,330 |
| 0.18 | 0.19 | 0.18 | 0.19 | 455.00 |
| Backtest Reviva Pharmaceuticals | | | Reviva Pharmaceuticals History | | | Reviva Pharmaceuticals Valuation | Previous | Next |
Reviva Pharmaceuticals Trading Date Momentum on November 25, 2024
| On November 26 2024 Reviva Pharmaceuticals Holdings was traded for 0.19 at the closing time. The highest daily price throughout the period was 0.19 and the lowest price was 0.18 . The daily volume was 455. The net trading volume on 11/26/2024 added to the next day price reduction. The trading delta at closing time to closing price of the next trading day was 9.52% . The trading delta at closing time to current closing price is 9.52% . |
Reviva Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Reviva Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Reviva Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Reviva financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Reviva Pharmaceuticals Stock history
Reviva Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Reviva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Reviva Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Reviva Pharmaceuticals stock prices may prove useful in developing a viable investing in Reviva Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 27.9 M | 15 M |
Reviva Pharmaceuticals Stock Technical Analysis
Reviva Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Reviva Pharmaceuticals Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Reviva Pharmaceuticals Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Reviva Pharmaceuticals November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Reviva Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Reviva Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Reviva Pharmaceuticals stock market strength indicators, traders can identify Reviva Pharmaceuticals Holdings entry and exit signals to maximize returns
Reviva Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Reviva Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Reviva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Reviva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1311 | |||
| Jensen Alpha | 3.14 | |||
| Total Risk Alpha | 0.1461 | |||
| Sortino Ratio | 0.1604 | |||
| Treynor Ratio | (10.37) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Reviva Stock Analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.